Allergan Adds To Growth Areas With Acquisition Of Eye-Disease Compounds
This article was originally published in The Pink Sheet Daily
Executive Summary
Deal with UK’s Asterand nets preclinical prostaglandin receptor agonists with potential in glaucoma, other eye conditions.